Lv5
1340 积分 2024-02-28 加入
Remifentanil represses oxidative stress to relieve hepatic ischemia/reperfusion injury via regulating BACH1/PRDX1 axis
1个月前
已完结
Mitochondria-Targeted ROS-Scavenging Polymer Protects the Hepatocytes and Macrophages against Hepatic Ischemia-Reperfusion Injury
1个月前
已完结
TWEAK is an activator of Hippo-YAP signaling protecting against hepatic Ischemia/ reperfusion injury
2个月前
已完结
Liver ischemia reperfusion injury: Mechanisms, cellular pathways, and therapeutic approaches
2个月前
已完结
[Quadruple treatment with doxycycline, furazolidone, bismuth and proton pump inhibitor is still effective against Helicobacter pylori in our population]
3个月前
已关闭
Vonoprazan improves the efficacy of bismuth quadruple therapy containing doxycycline and metronidazole as first-line Helicobacter pylori treatment in penicillin-allergic patients: a randomized controlled trial
3个月前
已完结
Rifabutin-Based Triple Therapy Or Bismuth-Based Quadruple Regimen As Rescue Therapies For Helicobacter pylori Infection
4个月前
已完结
Rifabutin-Containing Triple Therapy Versus Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter, Randomized Controlled Trial
4个月前
已完结
Real-world efficacy of second-line therapies for Helicobacter pylori: a population-based study
4个月前
已完结
The Comparison of the Clinical Efficacy and Drug Tissue Distribution of Furazolidone and Tetracycline-quadruple Therapy in Helicobacter pylori Eradication
4个月前
已完结
皖公网安备34019202002308
